The Legal and Compliance team of MedTech Europe

The new MedTech Europe Code of Ethical Business Practice (the “Code”) came in force on the 1 st January 2017 and replaces the Eucomed Code of Ethical Business Practices and the EDMA Code of Ethics. The Code allows for an additional year to phase out direct sponsorship by the entire medtech industry but this may be a good time to take stock of the situation; inquire if there are still grey areas and what are the opportunities going forward, therefore this letter. Over the last 2-3 years we tried through different means, such as the creation of an advisory group; bilateral discussions, panel discussions, etc to ensure that our partners, i.e. Healthcare Professionals (HCPs), Hospitals, Scientific Societies and Professional Congress Organisers (PCOs) are aware of the Code developments, but in order to get everyone on the same page, we thought to provide a short summary of what lies ahead for 2017: -- 1st January 2017 – the Code came into force The Code became binding for MedTech Europe Corporate Members . For Healthcare Organisations (HCOs) and Professional Congress Organisers that means that these companies have started to apply stricter rules when providing Educational Grants. -- Throughout 2017 - Outreach to European HCPs, medical societies and PCOs will continue The double objective of this outreach is for MedTech Europe to clarify any grey areas that you may still have on the new MTE Code and to ensure that going forward, the collaboration between the healthcare community and industry continues to the best interest of the patient. One event, where discussions, formal and informal, within the Healthcare Community will take place is the Global MedTech Compliance Conference (GMTCC) on 3-4 th May in Amsterdam. Please consider this as an official invitation to attend! -- Spring 2017 – Ethical MedTech Website Presently, the...